Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Adverse events reported

From: Effects of 52 weeks of precuneus rTMS in Alzheimer’s disease patients: a randomized trial

Adverse Events

rTMS (number of patients/%)

Sham (number of patients/%)

Mild headache

3 (11.5%)

1 (4.5%)

Skin discomfort

2 (7.7%)

2 (9%)

Scalp discomfort

4 (15.4%)

2 (9%)

Neck pain

1 (3.8%)

2 (9%)

Stiffness

0 (0%)

1 (4.5%)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193